These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 1684242

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cardiovascular effects of bevantolol, a selective beta 1-adrenoceptor antagonist with a novel pharmacological profile.
    Dukes ID, Vaughan Williams EM.
    Br J Pharmacol; 1985 Feb; 84(2):365-80. PubMed ID: 2858236
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations.
    Ledda F, Mantelli L, Manzini S, Amerini S, Mugelli A.
    J Cardiovasc Pharmacol; 1981 Feb; 3(6):1162-73. PubMed ID: 6173515
    [Abstract] [Full Text] [Related]

  • 25. Electromechanical effects of bepridil on rabbit isolated hearts.
    Anno T, Furuta T, Itoh M, Kodama I, Toyama J, Yamada K.
    Br J Pharmacol; 1984 Jan; 81(1):41-7. PubMed ID: 6608388
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
    Kobinger W, Lillie C.
    Eur J Pharmacol; 1984 Sep 03; 104(1-2):9-18. PubMed ID: 6499920
    [Abstract] [Full Text] [Related]

  • 27. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A, Gout B, Bonhomme M, Landais L, Faivre JF, Linee P, Poyser RH, Ruffolo RR.
    J Pharmacol Exp Ther; 1996 Feb 03; 276(2):637-46. PubMed ID: 8632331
    [Abstract] [Full Text] [Related]

  • 28. Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels.
    Pugsley MK, Goldin AL.
    Eur J Pharmacol; 1998 Jan 19; 342(1):93-104. PubMed ID: 9544797
    [Abstract] [Full Text] [Related]

  • 29. Comparative cardiac effects of KT-362 and verapamil in isolated heart--correlation to calcium channel current depression.
    Buljubasic N, Marijic J, Stowe DF, Gross GJ, Kampine JP, Bosnjak ZJ.
    J Cardiovasc Pharmacol; 1991 Oct 19; 18(4):594-604. PubMed ID: 1724538
    [Abstract] [Full Text] [Related]

  • 30. Differences in the cardiac actions of the calcium antagonists verapamil and nifedipine.
    Raschack M.
    Arzneimittelforschung; 1976 Oct 19; 26(7):1330-3. PubMed ID: 1036918
    [Abstract] [Full Text] [Related]

  • 31. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL, Liou SF, Liang JC, Huang YC, Chiang LC, Wu JR, Lin YT, Chen IJ.
    J Cardiovasc Pharmacol; 2000 Jan 19; 35(1):51-63. PubMed ID: 10630733
    [Abstract] [Full Text] [Related]

  • 32. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
    Chang GJ, Su MJ, Kuo SC, Lin TP, Lee YS.
    J Pharmacol Exp Ther; 2006 Jan 19; 316(1):380-91. PubMed ID: 16174797
    [Abstract] [Full Text] [Related]

  • 33. Frequency-dependent effects of propofol on atrioventricular nodal conduction in guinea pig isolated heart. Mechanism and potential antidysrhythmic properties.
    Alphin RS, Martens JR, Dennis DM.
    Anesthesiology; 1995 Aug 19; 83(2):382-94; discussion 24A. PubMed ID: 7631961
    [Abstract] [Full Text] [Related]

  • 34. The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade.
    Pugsley MK, Hayes ES, Saint DA, Walker MJA.
    Biomed Pharmacother; 2019 Mar 19; 111():427-435. PubMed ID: 30594781
    [Abstract] [Full Text] [Related]

  • 35. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
    Stark U, Stark G, Kasper K, Schwarzl I, Decrinis M, Pilger E, Tritthart HA.
    Pacing Clin Electrophysiol; 1997 Jan 19; 20(1 Pt 1):43-50. PubMed ID: 9121970
    [Abstract] [Full Text] [Related]

  • 36. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
    Damiano BP, Stump GL, Yagel SK.
    J Cardiovasc Pharmacol; 1991 Sep 19; 18(3):415-28. PubMed ID: 1720842
    [Abstract] [Full Text] [Related]

  • 37. The effects of indecainide, a new antidysrhythmic drug, on nodal tissues in the isolated rabbit heart.
    Dennis PD, Vaughan Williams EM.
    J Cardiovasc Pharmacol; 1986 Sep 19; 8(1):1-5. PubMed ID: 2419671
    [Abstract] [Full Text] [Related]

  • 38. Effects of S-1389 (711389-S), a new antiarrhythmic agent, on the conduction in perfused guinea pig hearts.
    Ninomiya M, Tani T, Ueda M.
    Jpn J Pharmacol; 1989 Dec 19; 51(4):555-62. PubMed ID: 2615048
    [Abstract] [Full Text] [Related]

  • 39. The effects of bisaramil on experimental arrhythmias.
    Paróczai M, Kárpáti E, Solti F.
    Pharmacol Res; 1990 Dec 19; 22(4):463-80. PubMed ID: 2402479
    [Abstract] [Full Text] [Related]

  • 40. In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic, and anti-angiotensin II effects.
    Gautier P, Guillemare E, Djandjighian L, Marion A, Planchenault J, Bernhart C, Herbert JM, Nisato D.
    J Cardiovasc Pharmacol; 2004 Aug 19; 44(2):244-57. PubMed ID: 15243307
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.